193 related articles for article (PubMed ID: 33183055)
1. Optimized stratification of risk factors in and beyond the CHA2DS2-VASc score to differentiate the real thromboembolic risk in mainland China: a systematic review and meta-analysis.
Li W; Zeng X; Xu L; Wang T; Lin W; Li Y; Luo Y; Luo B
Ann Palliat Med; 2020 Nov; 9(6):4252-4261. PubMed ID: 33183055
[TBL] [Abstract][Full Text] [Related]
2. [The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].
Liu XB; Jia ZX; Xia SJ; He L; Lu SX; Guo XY; Li SN; Liu N; Jiang CX; Sang CH; Tang RB; Long DY; Yu RH; Bai R; Wu JH; Du X; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):735-739. PubMed ID: 32957755
[No Abstract] [Full Text] [Related]
3. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
4. CHA
Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
[TBL] [Abstract][Full Text] [Related]
5. CHA
Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
[TBL] [Abstract][Full Text] [Related]
6. Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis.
Joundi RA; Cipriano LE; Sposato LA; Saposnik G;
Stroke; 2016 May; 47(5):1364-7. PubMed ID: 27026630
[TBL] [Abstract][Full Text] [Related]
7. LDL Cholesterol and Ischemic Stroke in Patients with Nonvalvular Atrial Fibrillation.
Omelchenko A; Hornik-Lurie T; Gabay H; Minha S; Assali A; Pereg D
Am J Med; 2021 Apr; 134(4):507-513. PubMed ID: 33002488
[TBL] [Abstract][Full Text] [Related]
8. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386
[TBL] [Abstract][Full Text] [Related]
9. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
[TBL] [Abstract][Full Text] [Related]
10. Should Every Patient With Atrial Fibrillation and a CHA2DS2-VASc Score of 1 Be Anticoagulated? A Systematic Review of 37,030 Patients.
Neefs J; Klamer TA; Krul SPJ; de Groot JR
Cardiol Rev; 2019; 27(5):249-255. PubMed ID: 31393287
[TBL] [Abstract][Full Text] [Related]
11. CHA
Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
[TBL] [Abstract][Full Text] [Related]
12. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
13. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M
Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957
[TBL] [Abstract][Full Text] [Related]
14. CHA
Guerra F; Scappini L; Maolo A; Campo G; Pavasini R; Shkoza M; Capucci A
Eur Heart J Acute Cardiovasc Care; 2018 Apr; 7(3):264-274. PubMed ID: 27708110
[TBL] [Abstract][Full Text] [Related]
15. [Impact of history of hypertension and blood pressure levels on the risk of thromboembolism in nonvalvular atrial fibrillation patients].
Zhu HJ; Jiang C; Kong XY; He L; Wang YF; Luo ZF; Xia SJ; Du X; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):721-727. PubMed ID: 32957753
[No Abstract] [Full Text] [Related]
16. CHA
Peacock WF; Tamayo S; Patel M; Sicignano N; Hopf KP; Yuan Z
Ann Emerg Med; 2017 May; 69(5):541-550.e1. PubMed ID: 27913059
[TBL] [Abstract][Full Text] [Related]
17. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.
Chao TF; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Hsieh MH; Chen SA
Can J Cardiol; 2014 Apr; 30(4):405-12. PubMed ID: 24582725
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA2DS2-VASc score.
Yan S; Li Q; Xia Z; Yan S; Wei Y; Hong K; Wu Y; Li J; Cheng X
Medicine (Baltimore); 2019 Feb; 98(8):e14549. PubMed ID: 30813164
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
Zhu WG; Xiong QM; Hong K
Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
[TBL] [Abstract][Full Text] [Related]
20. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
Saliba W; Rennert G
Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
